“Homo limes” — Cross-border people and cross-border citizenship
Oñati Socio-Legal Series · 14.04.2026
DOI: 10.35295/osls.iisl.2518 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oñati Socio-Legal Series, online erschienen am 14.04.2026. Verfasst von Joxerramon Bengoetxea und 1 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
MacCormick made an important contribution to Jurisprudence and Sociology of Law through his distinction between the norm-giver and the norm-user perspectives. Norm-givers and norm users, in his scheme, are in the same political community, in distinct communities with distinct institutions: users and givers share the same jurisdiction. But there are special cases of norm-users that are carrying out their ordinary lives in different communities. We can call them cross-border people. They live one part of their lives in one community and another part of their lives in another community, and both are bordering, and often share some features besides territorial continuity. As norm users they can belong to two different communities of norm users. As citizens, they can belong to two different demoi at the same time. We shall be applying these considerations to the Basque border regions to ask whether cross-border relationships are generating a new type of cross-border citizenship.
Zitieren
APA
Bengoetxea, J., & Mariscal, I. P. (2026). “Homo limes” — Cross-border people and cross-border citizenship. Oñati Socio-Legal Series. https://doi.org/10.35295/osls.iisl.2518
Vancouver
Bengoetxea J, Mariscal IP. “Homo limes” — Cross-border people and cross-border citizenship. Oñati Socio-Legal Series. 2026. doi:10.35295/osls.iisl.2518
BibTeX
@article{Bengoetxea2026,
author = {Bengoetxea, Joxerramon and Mariscal, Ihintza Palacin},
title = {“Homo limes” — Cross-border people and cross-border citizenship},
journal = {Oñati Socio-Legal Series},
year = {2026},
doi = {10.35295/osls.iisl.2518}
}
EUVIMED